Trending...
- Sign Up Your Pet, Feed a Family - 183
- California: Following Kristi Noem's firing, Governor Newsom demands DHS redirect funding from Noem's failed ad campaign to LA recovery
- Boxaloo Launches Load Board for Box Trucks, Sprinters, Cargo Vans, and Hotshots
IRVINE, Calif. and LONDON, July 22, 2024 ~ London, UK - Medical and Commercial International Limited (MCI), a leading specialized liability underwriting company, has joined forces with GATC Health Corp, a technology company utilizing artificial intelligence in drug discovery, to launch a groundbreaking program that will revolutionize the financing of clinical trials. This first-of-its-kind initiative, approved by Lloyd's of London, will provide insurance coverage for biotech companies in the event of trial failure.
The partnership between MCI and GATC Health aims to mitigate the financial risks associated with medical innovation and research. By utilizing GATC Health's proprietary AI technology, which accurately forecasts clinical trial endpoints, this new insurance model will significantly enhance risk assessment and promote the growth of therapeutic drug development.
MCI CEO Phil Trafford expressed excitement about this new venture, stating that "clinical trial funding insurance is a revolutionary product with high demand in the market." He believes that working alongside lenders and investors, this program will not only support medical innovation but also provide unparalleled risk assessment accuracy.
More on The Californer
The biotech industry has long struggled with securing funding for drug development projects without compromising equity or control of their company. This new program addresses these challenges by utilizing GATC Health's technology to enhance the risk selection process and bring more therapeutic drugs to market.
Ben Canagaretna, Global Managing Director of Acrisure Re Corporate Advisory & Solutions (ARCAS), an international financing and consulting firm responsible for program sales and distribution, praised GATC Health's AI technology for enabling this unique combination of financing and insurance. He also noted that the response from biotech companies and large brokerage firms has exceeded expectations, highlighting the pent-up demand for innovative financing programs.
GATC Health CEO John Stroh emphasized their focus on using AI technology to develop safer and more effective drugs in less time and with less money. Through their partnership with MCI backed by Lloyd's of London, they aim to transform the financial model of drug development and bring better treatments to those in need.
More on The Californer
This collaboration between MCI and GATC Health, with the backing of Lloyd's, marks a significant development in the insurance industry. It promises to reshape the landscape of clinical trial funding and provide stakeholders in the biotech industry with enhanced risk management tools to unlock groundbreaking medical innovations.
GATC Health's Multiomics Advanced Technology™ (MAT) platform, which utilizes AI and machine learning to simulate human physiology, has already shown promising results. In just two years, it has discovered and tested seven drug candidates with the potential to create 10 to 12 novel molecules each year. With this technology, the likelihood of clinical trial success is significantly increased.
The launch of this program marks a new era in clinical trial financing, where innovative technology and insurance come together to support medical innovation and bring life-changing treatments to those who need them most. With Lloyd's endorsement, this partnership between MCI and GATC Health is set to transform the drug development landscape for years to come.
The partnership between MCI and GATC Health aims to mitigate the financial risks associated with medical innovation and research. By utilizing GATC Health's proprietary AI technology, which accurately forecasts clinical trial endpoints, this new insurance model will significantly enhance risk assessment and promote the growth of therapeutic drug development.
MCI CEO Phil Trafford expressed excitement about this new venture, stating that "clinical trial funding insurance is a revolutionary product with high demand in the market." He believes that working alongside lenders and investors, this program will not only support medical innovation but also provide unparalleled risk assessment accuracy.
More on The Californer
- "The Mystery of Emma Thorn" Wins Again with Nomination & Official Selection of the New Media Film
- Fresh Lifelines for Youth Appoints Laksmi Lagares as Vice President of Development
- RAW Marketing Agency Expands Nationwide Serving Small Businesses in Los Angeles, Miami and New York
- California: Governor Newsom highlights mental health resources for veterans as Middle East conflict continues
- The Rise of Designer Pet Furniture: Why Dog Homes Are Becoming Part of Modern Interior Design
The biotech industry has long struggled with securing funding for drug development projects without compromising equity or control of their company. This new program addresses these challenges by utilizing GATC Health's technology to enhance the risk selection process and bring more therapeutic drugs to market.
Ben Canagaretna, Global Managing Director of Acrisure Re Corporate Advisory & Solutions (ARCAS), an international financing and consulting firm responsible for program sales and distribution, praised GATC Health's AI technology for enabling this unique combination of financing and insurance. He also noted that the response from biotech companies and large brokerage firms has exceeded expectations, highlighting the pent-up demand for innovative financing programs.
GATC Health CEO John Stroh emphasized their focus on using AI technology to develop safer and more effective drugs in less time and with less money. Through their partnership with MCI backed by Lloyd's of London, they aim to transform the financial model of drug development and bring better treatments to those in need.
More on The Californer
- Attention Singers & Musicians: Are you Looking for your Next Big Song Hits? Meet the Motherlode!
- California Hearing Center: Premier Audiology Services for Palo Alto and Stanford Community Residents
- Fresh Hibiscus LLC Releases "Professional Architecture Kit" for Global Professionals
- Property Owners Next to Montecito Country Club Must Remove Hardscaping and Landscaping
- Fashion Sourcing The Supplier Of Choice For Fashion Giants Like Shein - Temu - Wish – AliExpress
This collaboration between MCI and GATC Health, with the backing of Lloyd's, marks a significant development in the insurance industry. It promises to reshape the landscape of clinical trial funding and provide stakeholders in the biotech industry with enhanced risk management tools to unlock groundbreaking medical innovations.
GATC Health's Multiomics Advanced Technology™ (MAT) platform, which utilizes AI and machine learning to simulate human physiology, has already shown promising results. In just two years, it has discovered and tested seven drug candidates with the potential to create 10 to 12 novel molecules each year. With this technology, the likelihood of clinical trial success is significantly increased.
The launch of this program marks a new era in clinical trial financing, where innovative technology and insurance come together to support medical innovation and bring life-changing treatments to those who need them most. With Lloyd's endorsement, this partnership between MCI and GATC Health is set to transform the drug development landscape for years to come.
Filed Under: Business
0 Comments
Latest on The Californer
- MVP to Showcase AI-Driven Inspection for SMT, Packaging, and Microelectronics at APEX EXPO 2026
- $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
- ASI Hosts 2026 Executive Business Summit for Global Partner Community
- Statement of Compassion from Honorable Pamela Price on Mass Shooting March 7, 2026 in Oakland, CA
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- Gift Ideas That Look Luxurious and Always Feel Special
- Community Leaders Gather in Corona for Dialogue & Friendship Iftar During Ramadan
- Reggae on the River Announces Phase 2 Lineup for 2026 Festival
- Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
- SEEAG's 13th Annual Ventura County Farm Day
- Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
- Wordly Enhances Live Subtitles & Captions Featureto Meet Global Demand
- H Mart to Open New Dublin Store on March 26, 2026
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- Meet and Greet Award Winning Authors Lizzy Stevens and Steve Miller
- The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
- Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
- San Diego Mental Health Clinic Expands Access to Structured Intensive Outpatient Care for Adults
- Organic Spray Tanning Continues to Rise in Popularity Among San Diego Residents